- Home
- NCTY vs TVGN Comparison
NCTY vs TVGN Comparison
Compare NCTY & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCTY | TVGN |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6M | 89.6M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | NCTY | TVGN |
|---|---|---|
| Price | $7.55 | $0.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 41.0K | ★ 1.4M |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,305,175.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.95 | $0.38 |
| 52 Week High | $19.21 | $1.92 |
Technical Indicators
Market Signals| Indicator | NCTY | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 39.67 |
| Support Level | $6.83 | $0.39 |
| Resistance Level | $7.64 | $0.47 |
| Average True Range (ATR) | 0.60 | 0.04 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 34.57 | 11.07 |
Price Performance
Historical ComparisonAbout NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.